Jump to navigation
This study aimed to determine the clinical characteristics and circumstances of death of people undergoing naltrexone treatment for opioid dependence.
The availability of controlled-released formulations of fentanyl and advanced delivery methods has seen substantial increases in the use of fentanyl worldwide since the 1990s.
The Bradford Hill criteria for assessing causality are useful in assembling evidence, including within complex policy analyses.
This study investigated Australian drinkers’ alcohol-related beliefs according to their alcohol risk status.
NCETA in collaboration with the Network of Alcohol and other Drugs Agencies (NSW, Australia) and Matua Raki (New Zealand), conducted a literature review examining the health and wellbeing of the AOD workforces in Australasia.
This comprehensive international examination brings together and explores state-of-the-art research on the link between stress and health outcomes.
This paper gives insight into the issues and complexities of Colorado’s pioneering and evolving attempt to regulate the use of pesticides on commercial cannabis plantations.
Take-home naloxone is recommended to prevent deaths from accidental overdose among people who use pharmaceutical opioids for chronic non cancer pain.
Methamphetamine dependence is a growing problem in Australia and globally. Currently, there are no approved pharmacotherapy options for the management of methamphetamine dependence.
The Australian Treatment Outcome Study (ATOS) is a landmark study of the pathways of heroin use and one of the few to be conducted outside of the US.
This report provides estimates of some of the alcohol-related harms in each of the 59 Western Australian Lower House electoral districts, based on the best available data.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Tuesday 15 October 2019